Literature DB >> 33390881

Endocrine Therapy for the Functional Recovery of Spinal Cord Injury.

Hui Wang1,2, Wen-Xian Zhou1,2, Jin-Feng Huang1,2, Xuan-Qi Zheng1,2, Hai-Jun Tian3, Bin Wang4, Wei-Li Fu5, Ai-Min Wu1,2.   

Abstract

Spinal cord injury (SCI) is a major cause of physical disability and leads to patient dissatisfaction with their quality of life. Patients with SCI usually exhibit severe clinical symptoms, including sensory and motor dysfunction below the injured levels, paraplegia, quadriplegia and urinary retention, which can exacerbate the substantial medical and social burdens. The major pathological change observed in SCI is inflammatory reaction, which induces demyelination, axonal degeneration, and the apoptosis and necrosis of neurons. Traditional medical treatments are mainly focused on the recovery of motor function and prevention of complications. To date, numerous studies have been conducted to explore the cellular and molecular mechanism of SCI and have proposed lots of effective treatments, but the clinical applications are still limited due to the complex pathogenesis and poor prognosis after SCI. Endocrine hormones are kinds of molecules that are synthesized by specialized endocrine organs and can participate in the regulation of multiple physiological activities, and their protective effects on several disorders have been widely discussed. In addition, many studies have identified that endocrine hormones can promote nerve regeneration and functional recovery in individuals with central nervous system diseases. Therefore, studies investigating the clinical applications of endocrine hormones as treatments for SCI are necessary. In this review, we described the neuroprotective roles of several endocrine hormones in SCI; endocrine hormone administration reduces cell death and promotes functional repair after SCI. We also proposed novel therapies for SCI.
Copyright © 2020 Wang, Zhou, Huang, Zheng, Tian, Wang, Fu and Wu.

Entities:  

Keywords:  basic fibroblast growth factor; endocrine hormone; erythropoietin; estrogen; spinal cord injury; testosterone; thyroid hormones

Year:  2020        PMID: 33390881      PMCID: PMC7773784          DOI: 10.3389/fnins.2020.590570

Source DB:  PubMed          Journal:  Front Neurosci        ISSN: 1662-453X            Impact factor:   4.677


  4 in total

1.  Spatiotemporal Dynamics of the Molecular Expression Pattern and Intercellular Interactions in the Glial Scar Response to Spinal Cord Injury.

Authors:  Leilei Gong; Yun Gu; Xiaoxiao Han; Chengcheng Luan; Chang Liu; Xinghui Wang; Yufeng Sun; Mengru Zheng; Mengya Fang; Shuhai Yang; Lai Xu; Hualin Sun; Bin Yu; Xiaosong Gu; Songlin Zhou
Journal:  Neurosci Bull       Date:  2022-07-05       Impact factor: 5.203

2.  A multimodality intervention to improve musculoskeletal health, function, metabolism, and well-being in spinal cord injury: study protocol for the FIT-SCI randomized controlled trial.

Authors:  K F Reid; T W Storer; K M Pencina; R Valderrabano; N K Latham; L Wilson; C Ghattas; R Dixon; A Nunes; N Bajdek; G Huang; S E Skeels; A P Lin; S M Merugumala; H J Liao; M L Bouxsein; R D Zafonte; S Bhasin
Journal:  BMC Musculoskelet Disord       Date:  2022-05-25       Impact factor: 2.562

3.  Growth Factors VEGF-A165 and FGF-2 as Multifunctional Biomolecules Governing Cell Adhesion and Proliferation.

Authors:  Antonín Sedlář; Martina Trávníčková; Roman Matějka; Šimon Pražák; Zuzana Mészáros; Pavla Bojarová; Lucie Bačáková; Vladimír Křen; Kristýna Slámová
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

Review 4.  Future Perspectives in Spinal Cord Repair: Brain as Saviour? TSCI with Concurrent TBI: Pathophysiological Interaction and Impact on MSC Treatment.

Authors:  Paul Köhli; Ellen Otto; Denise Jahn; Marie-Jacqueline Reisener; Jessika Appelt; Adibeh Rahmani; Nima Taheri; Johannes Keller; Matthias Pumberger; Serafeim Tsitsilonis
Journal:  Cells       Date:  2021-10-30       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.